These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24510833)

  • 1. Electroporation-mediated administration of candidate DNA vaccines against HIV-1.
    Vasan S
    Methods Mol Biol; 2014; 1121():291-307. PubMed ID: 24510833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation.
    Dolter KE; Evans CF; Ellefsen B; Song J; Boente-Carrera M; Vittorino R; Rosenberg TJ; Hannaman D; Vasan S
    Vaccine; 2011 Jan; 29(4):795-803. PubMed ID: 21094270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent antibody and T cell responses induced by HIV-1 DNA vaccine delivered by electroporation.
    Cristillo AD; Weiss D; Hudacik L; Restrepo S; Galmin L; Suschak J; Draghia-Akli R; Markham P; Pal R
    Biochem Biophys Res Commun; 2008 Feb; 366(1):29-35. PubMed ID: 18036339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definitive toxicology and biodistribution study of a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 (HIV-1) vaccine in rabbits.
    Pal R; Yu Q; Wang S; Kalyanaraman VS; Nair BC; Hudacik L; Whitney S; Keen T; Hung CL; Hocker L; Kennedy JS; Markham P; Lu S
    Vaccine; 2006 Feb; 24(8):1225-34. PubMed ID: 16219399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical development of intramuscular electroporation: providing a "boost" for DNA vaccines.
    Khan AS; Broderick KE; Sardesai NY
    Methods Mol Biol; 2014; 1121():279-89. PubMed ID: 24510832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation.
    Otten GR; Schaefer M; Doe B; Liu H; Megede JZ; Donnelly J; Rabussay D; Barnett S; Ulmer JB
    Vaccine; 2006 May; 24(21):4503-9. PubMed ID: 16181711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.
    Girard MP; Osmanov S; Assossou OM; Kieny MP
    Vaccine; 2011 Aug; 29(37):6191-218. PubMed ID: 21718747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
    Yu S; Feng X; Shu T; Matano T; Hasegawa M; Wang X; Ma H; Li H; Li Z; Zeng Y
    Vaccine; 2008 Nov; 26(48):6124-31. PubMed ID: 18812199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prime-boost strategies in DNA vaccines.
    Dale CJ; Thomson S; De Rose R; Ranasinghe C; Medveczky CJ; Pamungkas J; Boyle DB; Ramshaw IA; Kent SJ
    Methods Mol Med; 2006; 127():171-97. PubMed ID: 16988455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of DNA vaccine potency in rhesus macaques by electroporation.
    Otten G; Schaefer M; Doe B; Liu H; Srivastava I; zur Megede J; O'Hagan D; Donnelly J; Widera G; Rabussay D; Lewis MG; Barnett S; Ulmer JB
    Vaccine; 2004 Jun; 22(19):2489-93. PubMed ID: 15193413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques.
    Hirao LA; Wu L; Khan AS; Satishchandran A; Draghia-Akli R; Weiner DB
    Vaccine; 2008 Jan; 26(3):440-8. PubMed ID: 18082294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity.
    Buonaguro L; Devito C; Tornesello ML; Schröder U; Wahren B; Hinkula J; Buonaguro FM
    Vaccine; 2007 Aug; 25(32):5968-77. PubMed ID: 17629365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic and prophylactic DNA vaccines for HIV-1.
    Ramirez LA; Arango T; Boyer J
    Expert Opin Biol Ther; 2013 Apr; 13(4):563-73. PubMed ID: 23477730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses against a new HIV-1 p24-gp41/pCAGGS-IL-12 DNA vaccine in Balb/c mice.
    Roodbari F; Sabahi F; Sarbolouki MN; Barkhordari F; Adeli A; Jamedar A; Mahboudi F
    Iran J Immunol; 2012 Jun; 9(2):86-97. PubMed ID: 22735796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE; Abaitua F; Rodríguez D; Esteban M
    Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation.
    Bråve A; Gudmundsdotter L; Sandström E; Haller BK; Hallengärd D; Maltais AK; King AD; Stout RR; Blomberg P; Höglund U; Hejdeman B; Biberfeld G; Wahren B
    Vaccine; 2010 Nov; 28(51):8203-9. PubMed ID: 20951666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA and other technologies for HIV vaccines.
    Bowers M
    BETA; 1998 Apr; ():9-12, 28. PubMed ID: 11365275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost.
    Shinoda K; Xin KQ; Kojima Y; Saha S; Okuda K; Okuda K
    Clin Immunol; 2006 Apr; 119(1):32-7. PubMed ID: 16458074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected approaches for increasing HIV DNA vaccine immunogenicity in vivo.
    Hutnick NA; Myles DJ; Bian CB; Muthumani K; Weiner DB
    Curr Opin Virol; 2011 Oct; 1(4):233-40. PubMed ID: 22440782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.